Linagliptin in Schizophrenia Patients

Summary

Linagliptin in Schizophrenia Patients is a clinical trial^[1].

Key Facts

• Linagliptin in Schizophrenia Patients is in the country of Malaysia^[2].
• Linagliptin in Schizophrenia Patients's instance of is recorded as clinical trial^[3].
• Linagliptin in Schizophrenia Patients's start time is recorded as +2013-08-31T00:00:00Z^[4].
• Linagliptin in Schizophrenia Patients's end time is recorded as +2018-07-31T00:00:00Z^[5].
• Linagliptin in Schizophrenia Patients's contributor to the creative work or subject is recorded as University Kebangsaan Malaysia Medical Centre^[6].
• Linagliptin in Schizophrenia Patients's main subject is recorded as schizophrenia^[7].
• Linagliptin in Schizophrenia Patients's number of participants is recorded as {'unit': '1', 'amount': '+1'}^[8].
• Linagliptin in Schizophrenia Patients's title is recorded as A Pilot Study to Assess the Efficacy of Linagliptin as an Adjunct in Schizophrenia Patients^[9].
• Linagliptin in Schizophrenia Patients's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Linagliptin in Schizophrenia Patients's ClinicalTrials.gov ID is recorded as NCT01943019^[11].
• Linagliptin in Schizophrenia Patients's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[12].
• Linagliptin in Schizophrenia Patients's research intervention is recorded as linagliptin^[13].
• Linagliptin in Schizophrenia Patients's clinical trial phase is recorded as phase I clinical trial^[14].
• Linagliptin in Schizophrenia Patients's research site is recorded as University Kebangsaan Malaysia Medical Centre^[15].
• Linagliptin in Schizophrenia Patients's study type is recorded as interventional study^[16].